Kronenfeld Mark A. 4
4 · Pacira Pharmaceuticals, Inc. · Filed Mar 8, 2019
Insider Transaction Report
Form 4
Kronenfeld Mark A.
Director
Transactions
- Purchase
Common Stock
2019-03-06$38.72/sh+700$27,104→ 9,277 total - Purchase
Common Stock
2019-03-06$39.14/sh+1,000$39,140→ 10,277 total